Erratum: Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells (Molecular and Cellular Biochemistry DOI: 10.1007/s11010-012-1310-2);Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells

Molecular and Cellular Biochemistry

Volumn 366, Issue 1-2, 2012, Pages 319-334

  Seo, Hye Sook ^a   Choi, Han Seok ^a   Kim, Soon Re ^a   Choi, Youn Kyung ^a   Woo, Sang Mi ^a   Shin, Incheol ^b   Woo, Jong Kyu ^c   Park, Sang Yoon ^a   Shin, Yong Cheol ^a   Ko, Seong Kyu ^a  

^a Kyung Hee University   (South Korea)

^b Hanyang University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Apigenin; Apoptosis; HER2; NF B; p53; STAT3

Indexed keywords

APIGENIN; CASPASE 8; EPIDERMAL GROWTH FACTOR RECEPTOR 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; LAMIN B; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUBULIN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84862016307     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1356-1     Document Type: Erratum

References (59)

1. Zhang A, Wu Y, Lai HWL, Yew DT (2004) Apoptosis - a brief review. Neuroembryology 3:47-59
2. Kolb TM, Chang SH, Davis MA (2002) Biochemical and morphological events during okadaic acid-induced apoptosis of Tsc2-null ERC-18 cell line. Toxicol Pathol 30:235-246 (Pubitemid 34293048)
3. Waring P, Mullbacher A (1999) Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol 77:312-317 (Pubitemid 29370101)
4. Gupta S (2003) Molecular signaling in death receptor and mitochondrial pathways of apoptosis (review). Int J Oncol 22:15-20
5. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312 (Pubitemid 28406816)
6. Boulares AH, Yakovlev AG, Ivanova V, Stoica BA, Wang G, Iyer S, Smulson M (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem 274:22932-22940
7. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490 (Pubitemid 28391864)
8. Robinson AJ, Kunji ER, Gross A (2012) Mitochondrial carrier homolog 2 (MTCH2): the recruitment and evolution of a mitochondrial carrier protein to a critical player in apoptosis. Exp Cell Res. doi:10.1016/j.yexcr.2012.01.026
9. Qin S, Yang C, Li S, Xu C, Zhao Y, Ren H (2012) Smac: its role in apoptosis induction and use in lung cancer diagnosis and treatment. Cancer Lett 318:9-13
10. Gartel AL (2012) Mechanisms of apoptosis induced by anticancer compounds in melanoma cells. Curr Top Med Chem 12:50-52
11. Sirtori CR, Arnoldi A, Johnson SK (2005) Phytoestrogens: end of a tale? Ann Med 37:423-438 (Pubitemid 41476128)
12. Mense SM, Hei TK, Ganju RK, Bhat HK (2008) Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ Health Perspect 116:426-433 (Pubitemid 351864298)
13. Velentzis LS, Woodside JV, Cantwell MM, Leathem AJ, Keshtgar MR (2008) Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer 44:1799-1806
14. Duffy C, Cyr M (2003) Phytoestrogens: potential benefits and implications for breast cancer survivors. J Womens Health (Larchmt) 12:617-631 (Pubitemid 37266005)
15. Duffy C, Perez K, Partridge A (2007) Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin 57:260-277 (Pubitemid 47620124)
16. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK (1999) Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129:1628-1635 (Pubitemid 29406613)
17. de Souza PL, Russell PJ, Kearsley JH, Howes LG (2010) Clinical pharmacology of isoflavones and its relevance for potential prevention of prostate cancer. Nutr Rev 68:542-555
18. Toyomura K, Kono S (2002) Soybeans, soy foods, isoflavones and risk of colorectal cancer: a review of experimental and epidemiological data. Asian Pac J Cancer Prev 3:125-132
19. Singh AV, Franke AA, Blackburn GL, Zhou JR (2006) Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res 66:1851-1858 (Pubitemid 43259972)
20. Adjakly M, Bosviel R, Rabiau N, Boiteux JP, Bignon YJ, Guy L, Bernard-Gallon D (2011) DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 3:795-803
21. Qi W, Weber CR, Wasland K, Savkovic SD (2011) Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 11:219
22. Gupta S, Afaq F, Mukhtar H (2002) Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene 21:3727-3738 (Pubitemid 34620536)
23. Shukla S, Gupta S (2006) Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft. Mol Cancer Ther 5:843-852 (Pubitemid 43724583)
24. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20:1945-1952
25. Birt DF, Mitchell D, Gold B, Pour P, Pinch HC (1997) Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res 17:85-91 (Pubitemid 27116649)
26. Seo HS, Ju JH, Jang K, Shin I (2011) Induction of apoptotic cell death by phytoestrogens by up-regulating the levels of phosphop53 and p21 in normal and malignant estrogen receptor a-negative breast cells. Nutr Res 31:139-146
27. Lu HF, Chie YJ, Yang MS, Lee CS, Fu JJ, Yang JS, Tan TW, Wu SH, Ma YS, Ip SW, Chung JG (2010) Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway. Int J Oncol 36:1477-1484
28. Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ, Birt DF (2000) Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog 28:102-110 (Pubitemid 30432478)
29. Turktekin M, Konac E, Onen HI, Alp E, Yilmaz A, Menevse S (2011) Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29). J Med Food 14:1107-1117
30. Ruela-de-Sousa RR, Fuhler GM, Blom N, Ferreira CV, Aoyama H, Peppelenbosch MP (2010) Cytotoxicity of apigenin on leukemia cell lines: implications for prevention and therapy. Cell Death Dis 1:e19
31. Ujiki MB, Ding XZ, Salabat MR, Bentrem DJ, Golkar L, Milam B, Talamonti MS, Bell RH Jr, Iwamura T, Adrian TE (2006) Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer 5:76
32. Spevak CC, Park EH, Geballe AP, Pelletier J, Sachs MS (2006) Her-2 upstream open reading frame effects on the use of down-stream initiation codons. Biochem Biophys Res Commun 350:834-841 (Pubitemid 44739923)
33. Nielsen DL, Andersson M, Kamby C (2009) HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors. Cancer Treat Rev 35:121-136
34. Ménard S, Pupa SM, Campiglio M, Tagliabue E (2003) Biologic and therapeutic role of HER2 in cancer. Oncogene 22:6570-6578
35. Lipton A, Ali SM, Leitzel K, Demers L, Chinchilli V, Engle L, Harvey HA, Brady C, Nalin CM, Dugan M, Carney W, Allard J (2002) Elevated serum her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer. J Clin Oncol 20:1467-1472 (Pubitemid 34260524)
36. Tokunaga E, Oki E, Nishida K, Koga T, Egashira A, Morita M, Kakeji Y, Maehara Y (2006) Trastuzumab and breast cancer: developments and current status. Int J Clin Oncol 11:199-208 (Pubitemid 44087118)
37. Dean-Colomb W, Esteva FJ (2008) Her2-positive breast cancer: herceptin and beyond. Eur J Cancer 44:2806-2812
38. Shin I, Arteaga CL (2006) Expression of active akt protects against tamoxifen-induced apoptosis in MCF-7 cells. IUBMB Life 58:664-669 (Pubitemid 44691469)
39. Jänicke RU (2009) MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 117:219-221
40. Way TD, Kao MC, Lin JK (2004) Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem 279:4479-4489
41. Zheng PW, Chiang LC, Lin CC (2005) Apigenin induced apoptosis through p53-dependent pathway in human cervical carcinoma cells. Life Sci 76:1367-1379
42. Chiang LC, Ng LT, Lin IC, Kuo PL, Lin CC (2006) Anti-proliferative effect of apigenin and its apoptotic induction in human Hep G2 cells. Cancer Lett 237:207-214 (Pubitemid 43777073)
43. Schuler M, Green DR (2001) Mechanisms of p53-dependent apoptosis. Biochem Soc Trans 29:684-688 (Pubitemid 33131760)
44. Shen Y, White E (2001) p53-dependent apoptosis pathways. Adv Cancer Res 82:55-84 (Pubitemid 32613382)
45. Stiewe T, Putzer BM (2000) Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet 26:464-469
46. Polager S, Ginsberg D (2009) p53 and E2F: partners in life and death. Nat Rev Cancer 9:738-748
47. Adams JM, Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326 (Pubitemid 28406819)
48. de la Iglesia N, Konopka G, Puram SV, Chan JA, Bachoo RM, You MJ, Levy DE, Depinho RA, Bonni A (2008) Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Gene Dev 22:449-462 (Pubitemid 351272753)
49. Lewis HD, Winter A, Murphy TF, Tripathi S, Pandey VN, Barton BE (2008) STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5′ and 3′ ends. Mol Cancer Ther 7:1543-1550
50. Kortylewski M, Jove R, Yu H (2005) Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev 24:315-327 (Pubitemid 40922802)
51. Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H (2002) Roles of activated Src and STAT3 signaling in melanoma tumor cell growth. Oncogene 21:7001-7010 (Pubitemid 35252974)
52. Xie TX, Huang FJ, Aldape KD, Kang SH, Liu M, Gershenwald JE, Xie K, Sawaya R, Huang S (2006) Activation of STAT3 in human melanoma promotes brain metastasis. Cancer Res 66:3188-3196
53. Sellers LA, Feniuk W, Humphrey PP, Lauder H (1999) Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation. J Biol Chem 274:16423-16430
54. Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R (2000) Activation of STAT3 in v-Src-transformed fibroblasts requires cooperation of JAK1 kinase activity. J Biol Chem 275:24935-24944 (Pubitemid 30626601)
55. Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J, Jove R (2006) Resveratrol inhibits Src and STAT3 signaling and induces the apoptosis of malignant cells containing activated STAT3 protein. Mol Cancer Ther 5:621-629
56. He G, Karin M (2011) NF-κB and STAT3-key players in liver inflammation and cancer. Cell Res 21:159-168
57. Xiao G, Fu J (2011) NF-jB and cancer: a paradigm of Yin-Yang. Am J Cancer Res 1:192-221
58. Tolaney SM, Krop IE (2009) Mechanisms of trastuzumab resistance in breast cancer. Anticancer Agents Med Chem 9:348-355
59. Buzdar AU (2009) Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer. Ann Oncol 20:993-999